ID: ALA2179067

Max Phase: Preclinical

Molecular Formula: C31H42N4O2

Molecular Weight: 502.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CCOc1cccc(Nc2nc(C)cc(-c3ccc(OCCC4CCCCC4)cc3)n2)c1

Standard InChI:  InChI=1S/C31H42N4O2/c1-4-35(5-2)19-21-37-29-13-9-12-27(23-29)33-31-32-24(3)22-30(34-31)26-14-16-28(17-15-26)36-20-18-25-10-7-6-8-11-25/h9,12-17,22-23,25H,4-8,10-11,18-21H2,1-3H3,(H,32,33,34)

Standard InChI Key:  KXHQXABLTUZEMM-UHFFFAOYSA-N

Associated Targets(Human)

AGER Tchem Advanced glycosylation end product-specific receptor (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C6 (2371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ager Advanced glycosylation end product-specific receptor (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 502.70Molecular Weight (Monoisotopic): 502.3308AlogP: 7.27#Rotatable Bonds: 13
Polar Surface Area: 59.51Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.04CX Basic pKa: 9.32CX LogP: 7.23CX LogD: 5.31
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.27Np Likeness Score: -1.32

References

1. Han YT, Choi GI, Son D, Kim NJ, Yun H, Lee S, Chang DJ, Hong HS, Kim H, Ha HJ, Kim YH, Park HJ, Lee J, Suh YG..  (2012)  Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors.,  55  (21): [PMID:22742537] [10.1021/jm300172z]

Source